Essential Role of Monocyte Chemoattractant Protein-1 in Development of Restenotic Changes (Neointimal Hyperplasia and Constrictive Remodeling) After Balloon Angioplasty in Hypercholesterolemic Rabbits
- 18 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (24) , 2905-2910
- https://doi.org/10.1161/01.cir.0000018603.67989.71
Abstract
Background— Renarrowing of dilated arterial sites (restenosis) hampers the clinical benefits of coronary angioplasty. Infiltration and activation of monocytes in the arterial wall mediated by monocyte chemoattractant protein-1 (MCP-1) might be a major cause of restenosis after angioplasty. However, there is no direct evidence to support a definite role of MCP-1 in the development of restenosis. Methods and Results— We recently devised a new strategy for anti–MCP-1 gene therapy by transfecting an N-terminal deletion mutant of the MCP-1 gene into skeletal muscles. We used this strategy to investigate the role of MCP-1 in the development of restenotic changes after balloon injury in the carotid artery in hypercholesterolemic rabbits. Intramuscular transfection of the mutant MCP-1 gene suppressed monocyte infiltration/activation in the injured arterial wall and thus attenuated the development of neointimal hyperplasia and negative remodeling. Conclusions— MCP-1–mediated monocyte infiltration is necessary in t...Keywords
This publication has 14 references indexed in Scilit:
- Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesisThe FASEB Journal, 2000
- Treatment of murine lupus with cDNA encoding IFN-γR/FcJournal of Clinical Investigation, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactionsCytokine & Growth Factor Reviews, 1998
- Restenosis Revisited — New Targets, New TherapiesNew England Journal of Medicine, 1997
- Probucol and Multivitamins in the Prevention of Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1997
- Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.Journal of Clinical Investigation, 1997
- Heart rate and heart rate variability changes induced by right atrial pacingInternational Journal of Cardiology, 1996
- Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1994
- Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.Proceedings of the National Academy of Sciences, 1991